Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Lisa Alison Prosser, Ph.D.

TitleAdjunct Associate Professor in the Department of Health Policy and Management
InstitutionHarvard School of Public Health
DepartmentHealth Policy and Management
AddressU of Michigan Health System
Rm 6E14
300 N Ingalls St
Ann Arbor MI 48109
Phone617/509-9914
Other Positions
TitleLecturer on Population Medicine
InstitutionHarvard Pilgrim Healthcare
DepartmentPopulation Medicine


 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Wittenberg E, Saada A, Prosser LA. How illness affects family members: a qualitative interview survey. Patient. 2013 Dec; 6(4):257-68.
    View in: PubMed
  2. Ungar WJ, Prosser LA, Burnett HF. Values and evidence colliding: health technology assessment in child health. Expert Rev Pharmacoecon Outcomes Res. 2013 Aug; 13(4):417-9.
    View in: PubMed
  3. Zickafoose JS, Decamp LR, Prosser LA. Association between Enhanced Access Services in Pediatric Primary Care and Utilization of Emergency Departments: A National Parent Survey. J Pediatr. 2013 Nov; 163(5):1389-1395.e6.
    View in: PubMed
  4. Wittenberg E, Prosser LA. Disutility of illness for caregivers and families: a systematic review of the literature. Pharmacoeconomics. 2013 Jun; 31(6):489-500.
    View in: PubMed
  5. Prosser LA, Payne K, Rusinak D, Shi P, Messonnier M. Using a Discrete Choice Experiment to Elicit Time Trade-Off and Willingness-to-Pay Amounts for Influenza Health-Related Quality of Life at Different Ages. Pharmacoeconomics. 2013 Apr; 31(4):305-15.
    View in: PubMed
  6. Vandorsten JP, Dodson WC, Espeland MA, Grobman WA, Guise JM, Mercer BM, Minkoff HL, Poindexter B, Prosser LA, Sawaya GF, Scott JR, Silver RM, Smith L, Thomas A, Tita AT. NIH Consensus Development Conference: Diagnosing Gestational Diabetes Mellitus. NIH Consens State Sci Statements. 2013; 29(1):1-31.
    View in: PubMed
  7. Chang J, Freed GL, Prosser LA, Patel I, Erickson SR, Bagozzi RP, Balkrishnan R. Associations between physician financial incentives and the prescribing of anti-asthmatic medications in children in US outpatient settings. J Child Health Care. 2013 Jun; 17(2):125-37.
    View in: PubMed
  8. Chang J, Freed GL, Prosser LA, Patel I, Erickson SR, Bagozzi RP, Balkrishnan R. Comparisons of health care utilization outcomes in children with asthma enrolled in private insurance plans versus medicaid. J Pediatr Health Care. 2014 Jan-Feb; 28(1):71-9.
    View in: PubMed
  9. Zickafoose JS, Decamp LR, Sambuco DJ, Prosser LA. Parents' preferences for enhanced access to the pediatric medical home: a qualitative study. J Ambul Care Manage. 2013 Jan; 36(1):2-12.
    View in: PubMed
  10. Wittenberg E, Ritter GA, Prosser LA. Evidence of Spillover of Illness among Household Members: EQ-5D Scores from a US Sample. Med Decis Making. 2013 Feb; 33(2):235-43.
    View in: PubMed
  11. Song JW, Chung KC, Prosser LA. Treatment of ulnar neuropathy at the elbow: cost-utility analysis. J Hand Surg Am. 2012 Aug; 37(8):1617-1629.e3.
    View in: PubMed
  12. Prosser LA. Comparative effectiveness and child health. Pharmacoeconomics. 2012 Aug 1; 30(8):637-45.
    View in: PubMed
  13. Dempsey AF, Pangborn HM, Prosser LA. Cost-effectiveness of routine vaccination of adolescent females against cytomegalovirus. Vaccine. 2012 Jun 8; 30(27):4060-6.
    View in: PubMed
  14. Rhodes ET, Prosser LA, Hoerger TJ, Lieu T, Ludwig DS, Laffel LM. Estimated morbidity and mortality in adolescents and young adults diagnosed with Type 2 diabetes mellitus. Diabet Med. 2012 Apr; 29(4):453-63.
    View in: PubMed
  15. Gidengil C, Lieu TA, Payne K, Rusinak D, Messonnier M, Prosser LA. Parental and societal values for the risks and benefits of childhood combination vaccines. Vaccine. 2012 May 14; 30(23):3445-52.
    View in: PubMed
  16. Kimmel AD, Daniels N, Betancourt TS, Wood R, Prosser LA. Decision maker priorities for providing antiretroviral therapy in HIV-infected South Africans: a qualitative assessment. AIDS Care. 2012; 24(6):778-92.
    View in: PubMed
  17. Prosser LA, Grosse SD, Wittenberg E. Health utility elicitation: is there still a role for direct methods? Pharmacoeconomics. 2012 Feb 1; 30(2):83-6.
    View in: PubMed
  18. Rhodes ET, Goran MI, Lieu TA, Lustig RH, Prosser LA, Songer TJ, Weigensberg MJ, Weinstock RS, Gonzalez T, Rawluk K, Zoghbi RM, Ludwig DS, Laffel LM. Health-related quality of life in adolescents with or at risk for type 2 diabetes mellitus. J Pediatr. 2012 Jun; 160(6):911-7.
    View in: PubMed
  19. Gatwood J, Meltzer MI, Messonnier M, Ortega-Sanchez IR, Balkrishnan R, Prosser LA. Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations. Drugs. 2012 Jan 1; 72(1):35-48.
    View in: PubMed
  20. Lavelle TA, Meltzer MI, Gebremariam A, Lamarand K, Fiore AE, Prosser LA. Community-based values for 2009 pandemic influenza A H1N1 illnesses and vaccination-related adverse events. PLoS One. 2011; 6(12):e27777.
    View in: PubMed
  21. Lavelle TA, Uyeki TM, Prosser LA. Cost-effectiveness of oseltamivir treatment for children with uncomplicated seasonal influenza. J Pediatr. 2012 Jan; 160(1):67-73.e6.
    View in: PubMed
  22. Prosser LA, Lavelle TA, Fiore AE, Bridges CB, Reed C, Jain S, Dunham KM, Meltzer MI. Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States. PLoS One. 2011; 6(7):e22308.
    View in: PubMed
  23. Wittenberg E, Prosser LA. Ordering errors, objections and invariance in utility survey responses: a framework for understanding who, why and what to do. Appl Health Econ Health Policy. 2011 Jul 1; 9(4):225-41.
    View in: PubMed
  24. Eisenberg D, Freed GL, Davis MM, Singer D, Prosser LA. Valuing health at different ages: evidence from a nationally representative survey in the US. Appl Health Econ Health Policy. 2011 May 1; 9(3):149-56.
    View in: PubMed
  25. Bridges JF, Hauber AB, Marshall D, Lloyd A, Prosser LA, Regier DA, Johnson FR, Mauskopf J. Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011 Jun; 14(4):403-13.
    View in: PubMed
  26. Rhodes ET, Prosser LA, Lieu TA, Songer TJ, Ludwig DS, Laffel LM. Preferences for type 2 diabetes health states among adolescents with or at risk of type 2 diabetes mellitus. Pediatr Diabetes. 2011 Dec; 12(8):724-32.
    View in: PubMed
  27. Taveras EM, Gortmaker SL, Hohman KH, Horan CM, Kleinman KP, Mitchell K, Price S, Prosser LA, Rifas-Shiman SL, Gillman MW. Randomized controlled trial to improve primary care to prevent and manage childhood obesity: the High Five for Kids study. Arch Pediatr Adolesc Med. 2011 Aug; 165(8):714-22.
    View in: PubMed
  28. Belfort MB, Zupancic JA, Riera KM, Turner JH, Prosser LA. Health state preferences associated with weight status in children and adolescents. BMC Pediatr. 2011; 11:12.
    View in: PubMed
  29. Prosser LA, Payne K, Rusinak D, Shi P, Uyeki T, Messonnier M. Valuing health across the lifespan: health state preferences for seasonal influenza illnesses in patients of different ages. Value Health. 2011 Jan; 14(1):135-43.
    View in: PubMed
  30. Prosser LA, Meltzer MI, Fiore A, Epperson S, Bridges CB, Hinrichsen V, Lieu TA. Effects of adverse events on the projected population benefits and cost-effectiveness of using live attenuated influenza vaccine in children aged 6 months to 4 years. Arch Pediatr Adolesc Med. 2011 Feb; 165(2):112-8.
    View in: PubMed
  31. Wang YC, Cheung AM, Bibbins-Domingo K, Prosser LA, Cook NR, Goldman L, Gillman MW. Effectiveness and cost-effectiveness of blood pressure screening in adolescents in the United States. J Pediatr. 2011 Feb; 158(2):257-64.e1-7.
    View in: PubMed
  32. Grosse SD, Prosser LA, Asakawa K, Feeny D. QALY weights for neurosensory impairments in pediatric economic evaluations: case studies and a critique. Expert Rev Pharmacoecon Outcomes Res. 2010 Jun; 10(3):293-308.
    View in: PubMed
  33. McBrien KA, Kleinman KP, Abrams AM, Prosser LA. Use of outcomes to evaluate surveillance systems for bioterrorist attacks. BMC Med Inform Decis Mak. 2010; 10:25.
    View in: PubMed
  34. Lipstein EA, Vorono S, Browning MF, Green NS, Kemper AR, Knapp AA, Prosser LA, Perrin JM. Systematic evidence review of newborn screening and treatment of severe combined immunodeficiency. Pediatrics. 2010 May; 125(5):e1226-35.
    View in: PubMed
  35. Perrin JM, Knapp AA, Browning MF, Comeau AM, Green NS, Lipstein EA, Metterville DR, Prosser L, Queally D, Kemper AR. An evidence development process for newborn screening. Genet Med. 2010 Mar; 12(3):131-4.
    View in: PubMed
  36. Prosser LA, Kong CY, Rusinak D, Waisbren SL. Projected costs, risks, and benefits of expanded newborn screening for MCADD. Pediatrics. 2010 Feb; 125(2):e286-94.
    View in: PubMed
  37. Sonneville KR, La Pelle N, Taveras EM, Gillman MW, Prosser LA. Economic and other barriers to adopting recommendations to prevent childhood obesity: results of a focus group study with parents. BMC Pediatr. 2009; 9:81.
    View in: PubMed
  38. Lipstein EA, Perrin JM, Waisbren SE, Prosser LA. Impact of false-positive newborn metabolic screening results on early health care utilization. Genet Med. 2009 Oct; 11(10):716-21.
    View in: PubMed
  39. Prosser LA. Current challenges and future research in measuring preferences for pediatric health outcomes. J Pediatr. 2009 Jul; 155(1):7-9.
    View in: PubMed
  40. O'Brien MA, Prosser LA, Paradise JL, Ray GT, Kulldorff M, Kurs-Lasky M, Hinrichsen VL, Mehta J, Colborn DK, Lieu TA. New vaccines against otitis media: projected benefits and cost-effectiveness. Pediatrics. 2009 Jun; 123(6):1452-63.
    View in: PubMed
  41. Lieu TA, Ray GT, Ortega-Sanchez IR, Kleinman K, Rusinak D, Prosser LA. Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster. Pharmacoeconomics. 2009; 27(12):1005-16.
    View in: PubMed
  42. Wright DR, Wittenberg E, Swan JS, Miksad RA, Prosser LA. Methods for measuring temporary health States for cost-utility analyses. Pharmacoeconomics. 2009; 27(9):713-23.
    View in: PubMed
  43. Prosser LA, Ladapo JA, Rusinak D, Waisbren SE. Parental tolerance of false-positive newborn screening results. Arch Pediatr Adolesc Med. 2008 Sep; 162(9):870-6.
    View in: PubMed
  44. Ortega-Sanchez IR, Lee GM, Jacobs RJ, Prosser LA, Molinari NA, Zhang X, Baine WB, McCauley MM, Miller T. Projected cost-effectiveness of new vaccines for adolescents in the United States. Pediatrics. 2008 Jan; 121 Suppl 1:S63-78.
    View in: PubMed
  45. Prosser LA, O'Brien MA, Molinari NA, Hohman KH, Nichol KL, Messonnier ML, Lieu TA. Non-traditional settings for influenza vaccination of adults: costs and cost effectiveness. Pharmacoeconomics. 2008; 26(2):163-78.
    View in: PubMed
  46. Lieu TA, Ortega-Sanchez I, Ray GT, Rusinak D, Yih WK, Choo PW, Shui I, Kleinman K, Harpaz R, Prosser LA. Community and patient values for preventing herpes zoster. Pharmacoeconomics. 2008; 26(3):235-49.
    View in: PubMed
  47. Prosser LA, Corso PS. Measuring health-related quality of life for child maltreatment: a systematic literature review. Health Qual Life Outcomes. 2007; 5:42.
    View in: PubMed
  48. Prosser LA, Wittenberg E. Do risk attitudes differ across domains and respondent types? Med Decis Making. 2007 May-Jun; 27(3):281-7.
    View in: PubMed
  49. Eisenberg DM, Post DE, Davis RB, Connelly MT, Legedza AT, Hrbek AL, Prosser LA, Buring JE, Inui TS, Cherkin DC. Addition of choice of complementary therapies to usual care for acute low back pain: a randomized controlled trial. Spine (Phila Pa 1976). 2007 Jan 15; 32(2):151-8.
    View in: PubMed
  50. Ladapo JA, Neumann PJ, Keren R, Prosser LA. Valuing children's health: a comparison of cost-utility analyses for adult and paediatric health interventions in the US. Pharmacoeconomics. 2007; 25(10):817-28.
    View in: PubMed
  51. Ladapo JA, Neumann PJ, Keren R, Prosser LA. Valuing children's health: a comparison of cost-utility analyses for adult and pediatric health interventions. Pharmacoeconomics (in press). 2007.
  52. Simon SR, Rodriguez HP, Majumdar SR, Kleinman K, Warner C, Salem-Schatz S, Miroshnik I, Soumerai SB, Prosser LA. Economic analysis of a randomized trial of academic detailing interventions to improve use of antihypertensive medications. J Clin Hypertens (Greenwich). 2007 Jan; 9(1):15-20.
    View in: PubMed
  53. Prosser LA, Hammitt JK, Keren R. Measuring health preferences for use in cost-utility and benefit analyses of interventions in children: theoretical and methodological considerations. Pharmacoeconomics (in press). 2007.
  54. Prosser LA, Hammitt JK, Keren R. Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children: theoretical and methodological considerations. Pharmacoeconomics. 2007; 25(9):713-26.
    View in: PubMed
  55. Prosser LA, Ladapo JA, Waisbren SL. Expanded newborn screening: the effect of false positive test results on quality of life. Presented at the Annual Meeting of the Society for Medical Decision Making. 2006.
  56. Prosser LA, Wittenberg E. Valuing children's health: response issues with using parents as proxies. Presented at the Annual Meeting of the Society for Medical Decision Making. 2006.
  57. Prosser LA, Bridges CB, Uyeki TM, Hinrichsen VL, Meltzer MI, Molinari NA, Schwartz B, Thompson WW, Fukuda K, Lieu TA. Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerg Infect Dis. 2006 Oct; 12(10):1548-58.
    View in: PubMed
  58. Prosser LA, O'Brien MA, Molinari NA, Hohman KH, Nichol KL, Wortley PM, Messonnier ML, Lieu TA. . Cost-effectiveness of delivering adult influenza vaccination in non-traditional settings. Presented at the Annual Meeting of the American Society for Health Economists. 2006.
  59. Skelding PC, Majumdar SR, Kleinman K, Warner C, Salem-Schatz S, Miroshnik I, Prosser L, Simon SR. Clinical and nonclinical correlates of adherence to prescribing guidelines for hypertension in a large managed care organization. J Clin Hypertens (Greenwich). 2006 Jun; 8(6):414-9.
    View in: PubMed
  60. Wittenberg E, Halpern E, Divi N, Prosser LA, Araki SS, Weeks JC. The effect of age, race and gender on preference scores for hypothetical health states. Qual Life Res. 2006 May; 15(4):645-53.
    View in: PubMed
  61. Wittenberg E, Divi N, Halpern E, Araki SS, Prosser LA, Weeks JC. The effect of age, race and gender on utility values for hypothetical health states. . Quality of Life Research. 2006; 15(4):645-653.
  62. Skelding PC, Majumdar SR, Soumerai SB, Warner C, Salem-Schatz S, Kleinman K, Miroshnik I, Prosser LA, Simon SR. Clinical and non-clinical correlates of adherence to prescribing guidelines for hypertension in a large managed care organization. J Clin Hypertension. 2006; 8(6):414-419.
  63. Prosser LA, Griffin M, Keren R, Meltzer MI, Ortega-Sanches I, Herrara G, Messonnier ML, Bridges CB. Using economic evidence to prioritize subgroups during an influenza vaccine shortage. Medical Decision Making. 2006; 26(1):E77.
  64. Prosser LA, O'Brien MA, Molinari NA, Hohman KH, Nichol KL, Wortley PM, Messionier ML, Lieu TA. Cost-effectiveness of delivering adult influenza vaccination in non-traditional settings.6. Medical Decision Making. 2006; 26(1):E38.
  65. Gupta RS, Bewtra M, Prosser LA, Finkelstein JA. Predictors of hospital charges for children admitted with asthma. Ambul Pediatr. 2006 Jan-Feb; 6(1):15-20.
    View in: PubMed
  66. Simon SR, Majumdar SR, Prosser LA, Salem-Schatz S, Warner C, Kleinman K, Miroshnik I, Soumerai SB. Group versus individual academic detailing to improve the use of antihypertensive medications in primary care: a cluster-randomized controlled trial. Am J Med. 2005 May; 118(5):521-8.
    View in: PubMed
  67. Prosser LA, Bridges CB, Uyeki TM, Rêgo VH, Ray GT, Meltzer MI, Schwartz B, Thompson WW, Fukuda K, Lieu TA. Values for preventing influenza-related morbidity and vaccine adverse events in children. Health Qual Life Outcomes. 2005; 3:18.
    View in: PubMed
  68. Prosser LA, O'Brien MA, Hohman KH, Nichol KL, Wortley PM, Messonnier ML, Molinari NA, Lieu TA. Costs of delivering adult influenza vaccination in non-traditional settings. Value in Health. 2005; 8(3):244.
  69. Prosser LA, Concannon TW, Pearson SD, Hammitt JK. An internet survey of public preferences for characteristics of health interventions. Medical Decision Making. 2005; 25(1):E57.
  70. Prosser LA, Kuntz KM, Bar-Or A, Weinstein MC. Cost-effectiveness of interferon beta-1a, interferon beta-1b, and glatiramer acetate in newly diagnosed non-primary progressive multiple sclerosis. Value Health. 2004 Sep-Oct; 7(5):554-68.
    View in: PubMed
  71. Prosser LA, Ray GT, O'Brien M, Kleinman K, Santoli J, Lieu TA. Preferences and willingness to pay for health states prevented by pneumococcal conjugate vaccine. Pediatrics. 2004 Feb; 113(2):283-90.
    View in: PubMed
  72. Prosser LA, Kuntz KM, Bar-Or A, Weinstein MC. Cost-effectiveness of interferon beta-1a, interferon beta-1b, and glatiramer acetate in newly-diagnosed non-primary progressive multiple sclerosis. Value in Health. 2004; 7(5):554-568.
  73. Prosser LA, Lieu TA. . Comments on the Prosser et al approach to value disease reduction in children: In reply. [letter]. Pediatrics. 2004; 114:1375-6.
  74. Prosser LA, Uyeki TM, Bridges CB, Rego VH, Meltzer M, Schwartz B, Thompson WW, Fukuda K, Lieu TA. An economic analysis of rapid tests and antiviral treatments for influenza in children. Value in Health. 2004; 3:222-223.
  75. Prosser LA, Kuntz KM, Bar-Or A, Weinstein MC. Patient and community preferences for treatments and health states in multiple sclerosis. Mult Scler. 2003 Jun; 9(3):311-9.
    View in: PubMed
  76. Wang SJ, Middleton B, Prosser LA, Bardon CG, Spurr CD, Carchidi PJ, Kittler AF, Goldszer RC, Fairchild DG, Sussman AJ, Kuperman GJ, Bates DW. A cost-benefit analysis of electronic medical records in primary care. Am J Med. 2003 Apr 1; 114(5):397-403.
    View in: PubMed
  77. Prosser LA, Kuntz KM, Bar-Or A, Weinstein MC. Patient and community preferences for treatments and health states in multiple sclerosis. Multiple Sclerosis. 2003; 9:311-319.
  78. Lieu TA, Thompson KM, Prosser LA, O'Brien MA, Yusuf HR, Shefer AM, Weinstein MC, Rickert DL. Emerging issues in vaccine economics: perspectives from the USA. Expert Rev Vaccines. 2002 Dec; 1(4):433-42.
    View in: PubMed
  79. Prosser LA, Kuntz KM, Bar-Or A, Weinstein MC. The relationship between risk attitude and treatment choice in patients with relapsing-remitting multiple sclerosis. Med Decis Making. 2002 Nov-Dec; 22(6):506-13.
    View in: PubMed
  80. Prosser LA, Stinnett AA, Goldman L, Weinstein MC. Cost-effectiveness analyses [letter]. Ann Intern Med. 2001; 135(5):383.
  81. Prosser LA, Stinnett AA, Goldman PA, Williams LW, Hunink MG, Goldman L, Weinstein MC. Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics. Ann Intern Med. 2000 May 16; 132(10):769-79.
    View in: PubMed
  82. Prosser LA, Koplan JP, Neumann PJ, Weinstein MC. Barriers to using cost-effectiveness analysis in managed care decision making. Am J Manag Care. 2000 Feb; 6(2):173-9.
    View in: PubMed
  83. Prosser LA . Patient preferences and economic considerations in treatment decisions for multiple sclerosis [dissertation]. 2000.
  84. Prosser L, Canby A. Further validation of the Elderly Mobility Scale for measurement of mobility of hospitalized elderly people. Clin Rehabil. 1997 Nov; 11(4):338-43.
    View in: PubMed
  85. Prosser LA. Pharmaceutical research and development: the effects of increased competition on human resource strategies [master’s thesis]. 1992.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Justin Sayde (jsaydehsph.harvard.edu). HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Prosser's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_